KTH Holding AB has invested in Glycolink, a company developing a sustainable hydrogel technology, to support its transition from research to commercialization.
Information on Glycolink
Glycolink is a pioneering company offering a unique hydrogel based on a technology platform developed at the KTH Royal Institute of Technology. Their innovative approach combines a novel protein that acts as a crosslinker, binding to certain polysaccharides to create a 100% biocompatible and biodegradable hydrogel sourced from renewable resources. The protein is produced recombinantly in their laboratory, while the polysaccharide is cultivated from fungi on low-cost carbon substrates.
This innovative hydrogel shows versatile and tunable properties, comparable to other hydrogels, and can be processed without toxic chemicals, thereby significantly reducing production costs and waste footprints. Glycolink's technology has potential applications across various industries, particularly in cosmetics and life sciences.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Sweden
Sweden is known for its commitment to innovation and sustainability, particularly in the biotechnology and cosmetics industries. The country's robust research infrastructure, coupled with its focus on sustainability, has fostered a thriving e
Similar Deals
KTH Holding AB
invested in
Glycolink AB
in 2023
in a Seed Stage deal